HighVista Strategies’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.84M Buy
2025
Q1
$2.21M Hold
2024
Q4
$2.53M Hold
2024
Q3
$2.87M Sell
2024
Q2
$2.8M Sell
2024
Q1
$2.23M Sell
2023
Q4
$1.9M Buy
2023
Q3
$1.7M Buy
2023
Q2
$2.47M Buy